PMID- 15679721
OWN - NLM
STAT- MEDLINE
DCOM- 20050620
LR  - 20220408
IS  - 0105-4538 (Print)
IS  - 0105-4538 (Linking)
VI  - 60
IP  - 3
DP  - 2005 Mar
TI  - Epidemiological characterization of the intermittent and persistent types of 
      allergic rhinitis.
PG  - 350-3
AB  - BACKGROUND: A new classification of allergic rhinitis (AR) has been proposed by 
      the allergic rhinitis and its impact on asthma (ARIA) workgroup. The validity of 
      this new classification is still largely unknown, especially the extent to which 
      it differs from the classical seasonal/perennial (SAR/PAR) classification, and 
      how and whether intermittent and persistent types of AR, as defined by ARIA, 
      differ from each other. METHODS: Two-step cross-sectional, population-based, in 
      six Western Europe countries; telephone interview followed by clinical diagnosis 
      [including specific immunoglobulin E (IgE) measurements] in a selected subset. 
      RESULTS: Within the population with AR, 29% of the subjects had persistent AR. 
      There was no association between the intermittent/persistent and the SAR/PAR 
      classifications. Subjects with persistent AR had more severe symptoms, and higher 
      rate of self-awareness and previous diagnosis of AR; they were also clearly 
      distinct in their sensitization pattern and medication use. CONCLUSIONS: The 
      classic types of SAR/PAR cannot be used interchangeably with the new 
      classification of intermittent/persistent, as they do not represent the same 
      stratum of disease. There is also evidence that the persistent type describes a 
      distinct group with characteristics that differentiates them from intermittent 
      AR. These results support the validity of the new ARIA classification.
FAU - Bauchau, V
AU  - Bauchau V
AD  - UCB Pharma S.A., R and D, Clinical Epidemiology and Outcomes Research, Chemin du 
      Foriest, Braine-l'Alleud, Belgium.
FAU - Durham, S R
AU  - Durham SR
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Validation Study
PL  - Denmark
TA  - Allergy
JT  - Allergy
JID - 7804028
RN  - 37341-29-0 (Immunoglobulin E)
SB  - IM
MH  - Adult
MH  - Awareness
MH  - Chronic Disease
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - Hypersensitivity/*complications
MH  - Immunoglobulin E/blood
MH  - Incidence
MH  - Interviews as Topic
MH  - Male
MH  - Middle Aged
MH  - Predictive Value of Tests
MH  - Rhinitis/*classification/diagnosis/*epidemiology/etiology
MH  - Rhinitis, Allergic, Perennial/epidemiology
MH  - Rhinitis, Allergic, Seasonal/epidemiology
MH  - Severity of Illness Index
EDAT- 2005/02/01 09:00
MHDA- 2005/06/21 09:00
CRDT- 2005/02/01 09:00
PHST- 2005/02/01 09:00 [pubmed]
PHST- 2005/06/21 09:00 [medline]
PHST- 2005/02/01 09:00 [entrez]
AID - ALL751 [pii]
AID - 10.1111/j.1398-9995.2005.00751.x [doi]
PST - ppublish
SO  - Allergy. 2005 Mar;60(3):350-3. doi: 10.1111/j.1398-9995.2005.00751.x.